Novartis
NVS
NVS
876 hedge funds and large institutions have $18.7B invested in Novartis in 2016 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 322 increasing their positions, 339 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
4% less capital invested
Capital invested by funds: $19.5B → $18.7B (-$835M)
5% less repeat investments, than reductions
Existing positions increased: 322 | Existing positions reduced: 339
24% less funds holding in top 10
Funds holding in top 10: 37 → 28 (-9)
Holders
876
Holding in Top 10
28
Calls
$50M
Puts
$45M
Top Buyers
| 1 | +$62.9M | |
| 2 | +$54.3M | |
| 3 | +$36.3M | |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
+$24.5M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$21.2M |
Top Sellers
| 1 | -$122M | |
| 2 | -$70.5M | |
| 3 | -$62M | |
| 4 |
TH
TCTC Holdings
Dallas,
Texas
|
-$35.1M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$23.6M |